Qianbin Li

1.1k total citations
66 papers, 886 citations indexed

About

Qianbin Li is a scholar working on Molecular Biology, Organic Chemistry and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Qianbin Li has authored 66 papers receiving a total of 886 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 15 papers in Organic Chemistry and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Qianbin Li's work include Pulmonary Hypertension Research and Treatments (12 papers), Synthesis and biological activity (10 papers) and Peptidase Inhibition and Analysis (8 papers). Qianbin Li is often cited by papers focused on Pulmonary Hypertension Research and Treatments (12 papers), Synthesis and biological activity (10 papers) and Peptidase Inhibition and Analysis (8 papers). Qianbin Li collaborates with scholars based in China, United States and Norway. Qianbin Li's co-authors include Gaoyun Hu, Wenfang Xu, Zhuo Chen, Meng Lv, Shijun Zhang, Steven Grant, Hao Fang, Zutao Yu, Tai L. Guo and Kai Liu and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The FASEB Journal.

In The Last Decade

Qianbin Li

63 papers receiving 864 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qianbin Li China 18 467 295 157 135 65 66 886
Hélène Jûteau Canada 13 346 0.7× 654 2.2× 89 0.6× 88 0.7× 73 1.1× 22 1.4k
Heather N. Tinsley United States 18 775 1.7× 383 1.3× 168 1.1× 69 0.5× 21 0.3× 36 1.3k
Chong Hak Chae South Korea 14 347 0.7× 113 0.4× 106 0.7× 65 0.5× 34 0.5× 48 582
Mariano Redondo‐Horcajo Spain 23 779 1.7× 300 1.0× 111 0.7× 100 0.7× 21 0.3× 42 1.3k
Tanya Coleman United Kingdom 17 589 1.3× 147 0.5× 282 1.8× 84 0.6× 131 2.0× 28 1.1k
Daulat Bikram Khadka South Korea 17 352 0.8× 373 1.3× 103 0.7× 63 0.5× 18 0.3× 34 879
Mohamed M. Khalifa Egypt 23 612 1.3× 537 1.8× 150 1.0× 84 0.6× 15 0.2× 49 1.2k
Melvin J. Yu United States 17 402 0.9× 326 1.1× 422 2.7× 103 0.8× 61 0.9× 30 1.1k
De Lin United States 14 527 1.1× 133 0.5× 90 0.6× 39 0.3× 26 0.4× 23 1.1k
Pascal De Tullio Belgium 16 481 1.0× 128 0.4× 139 0.9× 102 0.8× 41 0.6× 43 1.1k

Countries citing papers authored by Qianbin Li

Since Specialization
Citations

This map shows the geographic impact of Qianbin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qianbin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qianbin Li more than expected).

Fields of papers citing papers by Qianbin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qianbin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qianbin Li. The network helps show where Qianbin Li may publish in the future.

Co-authorship network of co-authors of Qianbin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Qianbin Li. A scholar is included among the top collaborators of Qianbin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qianbin Li. Qianbin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yu, et al.. (2025). A novel pyridine-2-one AMPK inhibitor: Discovery, mechanism, and in vivo evaluation in a hypoxic pulmonary arterial hypertension rat model. European Journal of Medicinal Chemistry. 286. 117266–117266. 1 indexed citations
2.
Cao, Shuyang, Xisheng Weng, Lei Zhang, et al.. (2025). Discovery of Cdc20/Hsp90 Dual-Target Inhibitors with Potent Antitumor Activity for Therapy of Acquired Resistant Melanoma. Journal of Medicinal Chemistry. 68(21). 22428–22454. 1 indexed citations
3.
Li, Mengqi, et al.. (2024). Heat shock protein 110: A novel candidate for disease diagnosis and targeted therapy. Drug Discovery Today. 29(12). 104199–104199.
4.
Li, Junnan, et al.. (2024). Inhibition of breast cancer growth with AN-329, a novel Hsp110 inhibitor, by inactivating p-STAT3/c-Myc axis. Biomedicine & Pharmacotherapy. 181. 117694–117694. 1 indexed citations
5.
6.
Zhang, Lei, et al.. (2024). Design, Synthesis, and Biological Evaluation of Quinoline (Quinolinone) Derivatives as NADPH Oxidase (NOX) Inhibitors. Chemical Biology & Drug Design. 104(2). e14610–e14610. 1 indexed citations
7.
Wang, Shanshan, Qianbin Li, Kerun Cao, et al.. (2024). Facilitating microglia M2 polarization alleviates p-Synephrine-induced depressive-like behaviours in CSDS mice via the 5-HT6R-FYN-ERK1/2 pathway. International Immunopharmacology. 147. 113926–113926. 3 indexed citations
8.
Hu, Gaoyun, et al.. (2023). Discovery of Ureido-Based Apcin Analogues as Cdc20-specific Inhibitors against Cancer. Pharmaceuticals. 16(2). 304–304. 5 indexed citations
9.
Han, Jizhong, Xianjun Fang, Hongtao Li, et al.. (2023). A first-in-class inhibitor of Hsp110 molecular chaperones of pathogenic fungi. Nature Communications. 14(1). 2745–2745. 15 indexed citations
10.
Li, Hongtao, et al.. (2021). Interdomain interactions dictate the function of the Candida albicans Hsp110 protein Msi3. Journal of Biological Chemistry. 297(3). 101082–101082. 11 indexed citations
11.
Li, Lijun, Qi Chang, Zhuo Chen, et al.. (2020). Discovery of Novel Pyrazolo[3,4-b] Pyridine Derivatives with Dual Activities of Vascular Remodeling Inhibition and Vasodilation for the Treatment of Pulmonary Arterial Hypertension. Journal of Medicinal Chemistry. 63(19). 11215–11234. 33 indexed citations
12.
Chang, Qi, et al.. (2020). Drug repurposing and rediscovery: Design, synthesis and preliminary biological evaluation of 1-arylamino-3-aryloxypropan-2-ols as anti-melanoma agents. Bioorganic & Medicinal Chemistry. 28(9). 115404–115404. 9 indexed citations
13.
Zhao, Rui, et al.. (2020). New Insights Into Heat Shock Protein 90 in the Pathogenesis of Pulmonary Arterial Hypertension. Frontiers in Physiology. 11. 1081–1081. 6 indexed citations
14.
Chen, Yang, Nasui Wang, Qiongjing Yuan, et al.. (2019). The Protective Effect of Fluorofenidone against Cyclosporine A-Induced Nephrotoxicity. Kidney & Blood Pressure Research. 44(4). 656–668. 11 indexed citations
15.
Ma, Junlong, Heng Chen, Jie Yang, et al.. (2019). Binding pocket-based design, synthesis and biological evaluation of novel selective BRD4-BD1 inhibitors. Bioorganic & Medicinal Chemistry. 27(9). 1871–1881. 17 indexed citations
16.
Rui, Yi, et al.. (2016). Advances in soluble guanylate cyclase stimulator. 47(5). 536. 1 indexed citations
17.
Lv, Meng, Zhuo Chen, Gaoyun Hu, & Qianbin Li. (2014). Therapeutic strategies of diabetic nephropathy: recent progress and future perspectives. Drug Discovery Today. 20(3). 332–346. 75 indexed citations
18.
Zhu, Weixing, Jie Shen, Qianbin Li, et al.. (2013). Synthesis, Pharmacophores, and Mechanism Study of Pyridin‐2(1H)‐one Derivatives as Regulators of Translation Initiation Factor 3A. Archiv der Pharmazie. 346(9). 654–666. 12 indexed citations
19.
Li, Qianbin, Hao Fang, Xuejian Wang, & Wenfang Xu. (2010). Novel cyclic-imide peptidomimetics as aminopeptidase N inhibitors. Structure-based design, chemistry and activity evaluation. II. European Journal of Medicinal Chemistry. 45(4). 1618–1626. 22 indexed citations
20.
Li, Qianbin, Adnan M. Al‐Ayoubi, Hui Zheng, et al.. (2009). Structure–activity relationship (SAR) studies of 3-(2-amino-ethyl)-5-(4-ethoxy-benzylidene)-thiazolidine-2,4-dione: Development of potential substrate-specific ERK1/2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(21). 6042–6046. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hélène Jûteau Breakdown of academic impact, for papers by Heather N. Tinsley Breakdown of academic impact, for papers by Chong Hak Chae Breakdown of academic impact, for papers by Mariano Redondo‐Horcajo Breakdown of academic impact, for papers by Tanya Coleman Breakdown of academic impact, for papers by Daulat Bikram Khadka Breakdown of academic impact, for papers by Mohamed M. Khalifa Breakdown of academic impact, for papers by Melvin J. Yu Breakdown of academic impact, for papers by De Lin Breakdown of academic impact, for papers by Pascal De Tullio
Rankless by CCL
2026